BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21372208)

  • 1. Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.
    Falk RJ; Gross WL; Guillevin L; Hoffman G; Jayne DR; Jennette JC; Kallenberg CG; Luqmani R; Mahr AD; Matteson EL; Merkel PA; Specks U; Watts R
    J Am Soc Nephrol; 2011 Apr; 22(4):587-8. PubMed ID: 21372208
    [No Abstract]   [Full Text] [Related]  

  • 2. Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.
    Falk RJ; Gross WL; Guillevin L; Hoffman GS; Jayne DR; Jennette JC; Kallenberg CG; Luqmani R; Mahr AD; Matteson EL; Merkel PA; Specks U; Watts RA; ; ;
    Arthritis Rheum; 2011 Apr; 63(4):863-4. PubMed ID: 21374588
    [No Abstract]   [Full Text] [Related]  

  • 3. Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.
    Falk RJ; Gross WL; Guillevin L; Hoffman G; Jayne DR; Jennette JC; Kallenberg CG; Luqmani R; Mahr AD; Matteson EL; Merkel PA; Specks U; Watts R
    Ann Rheum Dis; 2011 Apr; 70(4):704. PubMed ID: 21372195
    [No Abstract]   [Full Text] [Related]  

  • 4. Differences in the incidence of microscopic polyangiitis and granulomatosis with polyangiitis (Wegener's). Is there a latitudinal gradient?
    Corral-Gudino L; Borao-Cengotita-Bengoa M; Lerma-Marquez JL; del Pino-Montes J
    J Rheumatol; 2011 Nov; 38(11):2494-6. PubMed ID: 22045937
    [No Abstract]   [Full Text] [Related]  

  • 5. A brief history of Wegener's granulomatosis: on limited, localized, and generalized forms of the disease: comment on the article by the Wegener's Granulomatosis Etanercept Trial Research Group.
    Lamprecht P; Gross WL
    Arthritis Rheum; 2004 Jan; 50(1):334-5; author reply 335-6. PubMed ID: 14730635
    [No Abstract]   [Full Text] [Related]  

  • 6. "Granulomatosis with polyangiitis (Wegener's)" for "Wegener granulomatosis": dermatology journals should also adopt the alternative name.
    Bachmeyer C; Halioua B
    JAMA Dermatol; 2013 May; 149(5):526-7. PubMed ID: 23677076
    [No Abstract]   [Full Text] [Related]  

  • 7. [Should Wegener's disease retain its name?].
    Mamianetti A
    Medicina (B Aires); 2009; 69(6):689-90. PubMed ID: 20053617
    [No Abstract]   [Full Text] [Related]  

  • 8. [Should we abandon the eponym 'Wegener's granulomatosis'? A historical excursion].
    Grzybowski A; Rohrbach JM
    Klin Monbl Augenheilkd; 2011 Jul; 228(7):641-3. PubMed ID: 21739402
    [No Abstract]   [Full Text] [Related]  

  • 9. [ANCA-associated forms of vasculitis].
    Helmchen U; Kneissler U; Prall F
    Verh Dtsch Ges Pathol; 1996; 80():38-45. PubMed ID: 9065053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Wegener's granulomatosis and microscopic polyangiitis].
    Pagnoux C
    Rev Prat; 2008 Mar; 58(5):522-32. PubMed ID: 18524109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Wegener's granulomatosis": the path traveled since 1931.
    Hoffman GS
    Medicine (Baltimore); 1994 Nov; 73(6):325-9. PubMed ID: 7984084
    [No Abstract]   [Full Text] [Related]  

  • 12. Pilot study to assess the frequency of fibromyalgia, depression, and sleep disorders in patients with granulomatosis with polyangiitis (Wegener's).
    Hajj-Ali RA; Wilke WS; Calabrese LH; Hoffman GS; Liu X; Bena J; Clark T; Langford CA
    Arthritis Care Res (Hoboken); 2011 Jun; 63(6):827-33. PubMed ID: 21337530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment strategies and outcome of induction-refractory Wegener's granulomatosis or microscopic polyangiitis: analysis of 32 patients with first-line induction-refractory disease in the WEGENT trial.
    Seror R; Pagnoux C; Ruivard M; Landru I; Wahl D; Rivière S; Aussant S; Mahr A; Cohen P; Mouthon L; Guillevin L;
    Ann Rheum Dis; 2010 Dec; 69(12):2125-30. PubMed ID: 20643762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma exchange in the treatment of Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and renal limited vasculitis.
    Casian A; Jayne D
    Curr Opin Rheumatol; 2011 Jan; 23(1):12-7. PubMed ID: 21124082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microscopic polyangiitis (microscopic polyarteritis).
    Jennette JC; Thomas DB; Falk RJ
    Semin Diagn Pathol; 2001 Feb; 18(1):3-13. PubMed ID: 11296991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric characterization of "early" and "late differentiated" T-cells including PR3-specific cells in granulomatosis with polyangiitis (Wegener's).
    Fagin U; Pitann S; Gross WL; Lamprecht P
    Cytometry B Clin Cytom; 2012 May; 82(3):173-5. PubMed ID: 22253078
    [No Abstract]   [Full Text] [Related]  

  • 17. Epidemiological features of Wegener's granulomatosis and microscopic polyangiitis: two diseases or one 'anti-neutrophil cytoplasm antibodies-associated vasculitis' entity?
    Mahr AD
    APMIS Suppl; 2009 Jun; (127):41-7. PubMed ID: 19515139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cell abnormalities in Wegener's granulomatosis and microscopic polyangiitis: role of CD25+-expressing B cells.
    Eriksson P; Sandell C; Backteman K; Ernerudh J
    J Rheumatol; 2010 Oct; 37(10):2086-95. PubMed ID: 20716663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa.
    Mohammad AJ; Jacobsson LT; Westman KW; Sturfelt G; Segelmark M
    Rheumatology (Oxford); 2009 Dec; 48(12):1560-5. PubMed ID: 19797309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wegener's granulomatosis: managing more than inflammation.
    Seo P
    Curr Opin Rheumatol; 2008 Jan; 20(1):10-6. PubMed ID: 18281851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.